EUVIMEDEUVIMED entdecken
Crossref

Photo‐Triggered ROS‐Responsive Supramolecular Nanoprodrugs for Targeted and Synergistic Chemo/Photodynamic/Gas Therapy

Jingtao Shi, Ke Ma, Yibo Yang, Yuxin Pei, Zhichao Pei iD

Chemistry – A European Journal · 2025

DOI: 10.1002/chem.202403514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Jingtao Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, 712100, P. R. China. Hauptthemen laut MEDLINE: Prodrugs, Reactive Oxygen Species, Photochemotherapy, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Project of Science andTechnology of Social Development in Shaanxi Province, Foundation of Shangluo Bureau of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photo‐triggered ROS‐responsive supramolecular nanoprodrugs (BNN6@GBTC NPs) are constructed via supramolecular self‐assembly of amphiphilic prodrug molecule (GBTC) and NO donor (BNN6). BNN6@GBTC NPs possess good stability, ROS responsiveness, and selective HepG2 cells targetability via overexpressed galactose receptors on the cell membrane. When BNN6@GBTC NPs are taken up by HepG2 cells, they can generate ROS upon light irradiation, which can not only be used for photodynamic therapy, but also cleave the thioketal linkage to release camptothecin for chemotherapy. Meanwhile, BNN6 triggering release NO for gas therapy. BNN6@GBTC NPs enable targeted and synergistic chemo/photodynamic/gas therapy, which results in reduced damage to normal cells and enhanced anti‐cancer efficacy in vitro . This work provides a novel approach for the design of nanoprodrugs based on supramolecular self‐assembly to achieve the multimodal synergistic anti‐cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsReactive Oxygen SpeciesPhotochemotherapyNanoparticlesHumansHep G2 CellsCamptothecinAntineoplastic AgentsPhotosensitizing AgentsLightCell Survival

Stichwörter der Autor:innen

Anti-cancerNanoprodrugROS-responsivenessSupramolecular self-assemblySynergistic therapy

Substanzen

ProdrugsReactive Oxygen SpeciesCamptothecinAntineoplastic AgentsPhotosensitizing Agents

Autor:innen und Institutionen

  • College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, 712100, P. R. China.
  • Shaanxi Key Laboratory of Comprehensive Utilization of Tailings Resources, College of Chemical Engineering and Modern Materials, Shangluo University, Shangluo, Shaanxi, 726000, P. R. China.

ORCID-Profile: Zhichao Pei

Förderung

  • National Natural Science Foundation of China
  • Project of Science andTechnology of Social Development in Shaanxi Province
  • Foundation of Shangluo Bureau of Science and Technology

Zitieren

APA

Shi, J., Ma, K., Yang, Y., Pei, Y., & Pei, Z. (2025). Photo‐Triggered ROS‐Responsive Supramolecular Nanoprodrugs for Targeted and Synergistic Chemo/Photodynamic/Gas Therapy. Chemistry – A European Journal. https://doi.org/10.1002/chem.202403514

Vancouver

Shi J, Ma K, Yang Y, Pei Y, Pei Z. Photo‐Triggered ROS‐Responsive Supramolecular Nanoprodrugs for Targeted and Synergistic Chemo/Photodynamic/Gas Therapy. Chemistry – A European Journal. 2025. doi:10.1002/chem.202403514

BibTeX
@article{Shi2025,
  author = {Shi, Jingtao and Ma, Ke and Yang, Yibo and Pei, Yuxin and Pei, Zhichao},
  title = {Photo‐Triggered ROS‐Responsive Supramolecular Nanoprodrugs for Targeted and Synergistic Chemo/Photodynamic/Gas Therapy},
  journal = {Chemistry – A European Journal},
  year = {2025},
  doi = {10.1002/chem.202403514}
}
Kostenlos starten →